MSU Drug Discovery

Toggle Accessibility Tools

Welcome to MSU Drug discovery 


  • MSU DD Seminar Series: Dr. John Beutler (NIH/NCI), Friday, October 23, at 9am 

  • "Hyperphosphorylated tau aggregation and cytotoxicity modulators screen identified prescription drugs linked to Alzheimer's disease and cognitive functions" Liu et al., Scientific Reports, October 2020

  • "Identification of New MmpL3 Inhibitors by Untargeted and Targeted Mutant Screens Defines MmpL3 Domains with Differential Resistance" Williams, et al., Antimicrobial Agents and Chemotherapy Sept. 2019



MSU DD Graphic

Upcoming Events

Sparty head logo
Drug Discovery Seminar Series 


ADDRC logo click

  • High throughput screening
  • Automated laboratory robotics
  • Hit selection

InVivo logo click

  • Efficacy testing in normal & disease models
  • Safety testing
  • Imaging
  • In vivo techical assistance
  • PK studies 


  • Active pharmaceutical ingredient development
  • Screening & target validation
  • Series identification & Scale-up

Other Resources Available:

Molecular Interaction ANalysis